Home / Buprenorphine, Combinations / Norway
NO ATC N07BC51 · updated 2 Nov 2026
Buprenorphine, Combinations shortage in Norway
Is there a Buprenorphine, Combinations shortage in Norway?
Yes. As of 2 Nov 2026, 5 Buprenorphine, Combinations products are reported short in Norway, the first since 19 Dec 2025. The company estimate for the return is 31 Dec 2026. Main reason: commercial decision or withdrawal.
Also short in Canada, Czechia, Sweden. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Suboxone 12 mg/3 mg sublingvalfilm, 28x1 stk dosepose | Indivior Europe Limited | 19 Dec 2025 | 31 Dec 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
| NO | Suboxone 16 mg/4 mg sublingvaltablett, 28 stk blisterpakning | Indivior Europe Limited | 19 Dec 2025 | 31 Dec 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
| NO | Suboxone 2 mg/0,5 mg sublingvalfilm, 28x1 stk dosepose | Indivior Europe Limited | 19 Dec 2025 | 31 Dec 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
| NO | Suboxone 2 mg/0,5 mg sublingvaltablett, 28 stk blisterpakning | Indivior Europe Limited | 19 Dec 2025 | 31 Dec 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
| NO | Suboxone 8 mg/2 mg sublingvalfilm, 28x1 stk dosepose | Indivior Europe Limited | 19 Dec 2025 | 31 Dec 2026 | Commercial decision or withdrawal Planlagt utfasing/avregistrering |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).